RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)

Completed · Not applicable

Conditions studied: Surgical Wound

In brief

The objective of this trial is to demonstrate the safety and effectiveness of the Cardiva VASCADE™ Vascular Closure System (VCS) in sealing femoral arterial access sites. Hypothesis: The Cardiva VASCADE™ VCS provides times to hemostasis (TTH) and time to ambulation (TTA) results that are less than manual compression by a clinically meaningful and statistically significant margin. The rate of major access site-related complications with the Cardiva VASCADE™ VCS is non-inferior to the major complication rates of manual compression for sealing femoral arterial access sites.

Key facts

Study ID
NCT01297322
Run by
Cardiva Medical, Inc.
People needed
420
Starts
2011-09-01
Expected to finish
2012-07-01
Last updated by the study team
2020-01-22

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.